The total return over the past 12 months is +102.59% vs. +16.94% for the S&P 500. So far it's up +32.41% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +102.59% | +73.92% | (3.82%) | N/A | N/A | N/A |
| Total Return CAGR | +102.59% | +73.92% | (3.82%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Design Therapeutics, Inc. (DSGN)
| Year | Start price | End price | DSGN Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $9.38 | $12.42 | +32.41% | +14.51% | +17.90% |
| 2025 | $6.17 | $9.38 | +52.03% | +17.72% | +34.31% |
| 2024 | $2.65 | $6.17 | +132.83% | +24.89% | +107.94% |
| 2023 | $10.26 | $2.65 | (74.17%) | +26.19% | (100.36%) |
| 2022 | $21.41 | $10.26 | (52.08%) | (18.17%) | (33.91%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
